An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Filed with HKEX · Stock code 9606 · · English
Duality Biotherapeutics, Inc. on 6ix
Earlier from Duality Biotherapeutics
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Next Day Disclosure Return
- 2026 Interim report
- DualityBio Announces China NMPA Acceptance of Biologics License Application Seeking Approval for Trastuzumab Pamirtecan for the Treatment of Unresectable or Metastatic HER2-Positive Adult Breast Cancer
- DualityBio (9606.HK) Announces 2025 Annual Results
Follow Duality Biotherapeutics into a list and get an email when it puts out news.
Follow Duality Biotherapeutics